Group 1 - The core point of the news is that Guanzhou Bibete Pharmaceutical Co., Ltd. has seen a stock price increase of 5.02%, reaching 57.08 CNY per share, with a total market capitalization of 25.688 billion CNY as of January 26 [1] - The company specializes in the independent research and development of innovative drugs and was established on January 19, 2012, with its listing date set for October 28, 2025 [1] Group 2 - According to data, Huaxia Fund has a significant holding in Bibete, with the Huaxia CSI Photovoltaic Industry ETF (012885) holding 2,789 shares, accounting for 0.01% of the fund's net value, making it the sixth largest holding [2] - The Huaxia CSI Photovoltaic Industry ETF has a current scale of 373 million CNY and has achieved a return of 16.54% this year, ranking 446 out of 5,579 in its category [2] - The fund has a one-year return of 56.88%, ranking 1,128 out of 4,270, but has experienced a loss of 28.7% since its inception on August 17, 2021 [2] Group 3 - The fund manager of the Huaxia CSI Photovoltaic Industry ETF is Li Jun, who has been in the position for 8 years and 49 days, managing a total asset size of 95.667 billion CNY [3] - During his tenure, the best fund return achieved was 146.12%, while the worst return was -39.56% [3]